![]() ![]() Areas timely for developing research: Identification and deployment of intermediate phenotypes in classification, research and clinical practice of psychiatry.Īlthough biomarker science is a field that is advancing rapidly in medicine as a whole, neurop-sychiatric disorders are still characterized by an absence of the biomarkers and laboratory tests that will promote new diagnostic and prognostic procedures. ![]() Are psychiatric biomarkers advanced enough to supplant it? Growing points: The need for biomarkers of psychiatric disorders has become more acute with the advent of new treatments which require precision and an individualized approach. Areas of controversy: The cross-sectional and longitudinal observation of psychopathology is the bedrock of current clinical practice. Areas of agreement: Availability of clinically useful biomarkers will improve the prognosis and outcome of psychiatric patients by helping in early diagnosis and delivery of individualized treatment. Sources of data: The data quoted in this paper are gathered from a range of sources encompassing scientific and journalistic both in print and electronic. In clinical practice, it undermines the validity of psychiatric diagnoses and hampers the delivery of personalized treatment. Introduction: The dearth of biomarkers limits the precision of our research into pathogenesis of psychiatric disorders and has slowed down the development of new drugs. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |